NEU 0.00% $20.71 neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-179

  1. 5,722 Posts.
    lightbulb Created with Sketch. 272


    An aquirer will likely have many other parts. So the exposure for Neurens assets would be highly diluted if a current shareholder invested in the aquirer.

    Thus it would`t be effective. IMO

    Best to get the maximum possible when/if TO occurs. Not good enough offer, send `em packing.

    It will really depend if there is more than 1 suitor.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.71
Change
0.000(0.00%)
Mkt cap ! $2.644B
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 350 $30.00
 

Sellers (Offers)

Price($) Vol. No.
$19.68 45 1
View Market Depth
Last trade - 16.16pm 24/05/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.